REQUEST A DEMO
Total
USD $0.00
Search more companies

Green Cross Holdings Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Management of Companies and Enterprises
Full name: Green Cross Holdings Corporation Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Green Cross Holdings Corporation operates as a holding company engaged in supervising and managing its affiliate companies. The company, through its subsidiaries, is engaged in manufacturing and selling of medicine and medical supplies, etc. Green Cross Holdings Corporation offers prescription drugs including Blood Derivatives, Vaccines, Cerebrovascular disease treatment, Hunter syndrome drug, Recombinant, Fibrinolytic Agent, and Herbal Medicines. The company is based in Yongin, Gyeonggi-do Province, South Korea. Green Cross Holdings Corporation was incorporated in 1967 as Sudo Microorganism Medical Supplies Company.

Headquarters
303 Green Cross Co Ltd, Guseonge-Up, Yongin-Si
Yongin; Gyeonggi; Postal Code: 446-770

Contact Details: Purchase the Green Cross Holdings Corporation report to view the information.

Website: http://www.greencross.com

Basic Information
Total Employees:
Purchase the Green Cross Holdings Corporation report to view the information.
Outstanding Shares:
Purchase the Green Cross Holdings Corporation report to view the information.
Registered Capital:
Purchase the Green Cross Holdings Corporation report to view the information.
Financial Auditors:
Purchase the Green Cross Holdings Corporation report to view the information.
Incorporation Date:
October 05, 1967
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
10.62%
Purchase this report to view the information.
3.59%
Purchase this report to view the information.
3.15%
Purchase this report to view the information.
2.44%
Purchase this report to view the information.
2.36%
Subsidiaries
Able Analytics
Gc Biopharma Do Brasil Consultoria De Negocios Ltda (Brazil)
Gc Biopharma Usa, Inc. (United States)
Company Performance
Financial values in the chart are available after Green Cross Holdings Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
5.66%
Total operating revenue
3.11%
Operating profit (EBIT)
-171.71%
Net Profit (Loss) for the Period
-70.76%
Total assets
4.3%
Total equity
-6.05%
Operating Profit Margin (ROS)
-4.84%
Net Profit Margin
-3.22%
Return on Equity (ROE)
-2.18%
Debt to Equity Ratio
18.53%
Quick Ratio
0%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?